# Thiamine as a Metabolic Resuscitator in Septic Shock

> **NCT01070810** · PHASE1,PHASE2 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 88 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** D5W
- **DRUG:** Thiamine

## Key facts

- **NCT ID:** NCT01070810
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2017-05-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01070810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01070810, "Thiamine as a Metabolic Resuscitator in Septic Shock". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01070810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*